Expressions of miR-193b and miR-338-3p in renal clear-cell carcinoma cells and their effects on biological function

被引:0
|
作者
Zhu, Guangbin [1 ]
Xie, Changying [2 ]
Li, Liliang [1 ]
机构
[1] Daqing Oilfield Gen Hosp, Dept Urol, 9 Zhongkang St, Daqing 163001, Heilongjiang, Peoples R China
[2] Daqing Oilfield Gen Hosp, Dept Nephrol, Daqing, Heilongjiang, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2019年 / 12卷 / 04期
关键词
miR-193b; miR-338-3p; renal clear cell carcinoma; proliferation; invasion; GASTRIC-CANCER CELLS; PROLIFERATION; INVASION; PATHWAY; KIDNEY; GROWTH; ZEB2;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective: To evaluate the expressions of miR-193b and miR-338-3p in renal clear-cell carcinoma cells and their effects on biological function. Methods: Cancer tissues, adjacent normal tissues, and serum samples were obtained from 34 patients with renal clear-cell carcinoma. Peripheral blood samples from 30 healthy subjects were used as controls. The expression levels of miR-193b and miR-338-3p in renal clear-cell carcinoma cells and serums and their effects on the proliferation and invasion of renal clear-cell carcinoma cells were analyzed. Results: The relative expression level of miR-193b was significantly higher in cancer tissues of patients with renal clear-cell carcinoma than in the adjacent noncancerous tissues (P<0.05). The relative expression of miR-338-3p was significantly lower in the cancer tissue than in the adjacent noncancerous tissues (P<0.05). The relative expression level of miR-193b in the serum of patients was significantly higher than that observed in the serum of healthy subjects (P<0.05). The relative expression level of miR-338-3p was significantly lower in patients than in healthy subjects (P<0.05). The results of MTT in vitro proliferation test showed statistical differences in the absorbance values of the three groups treated with miR-193b mimic at each time point (P<0.05). Transwell in vitro invasion test showed statistically significant differences in the number of invading cells in the three groups subjected to miR-193b mimic treatment (P<0.05). Significant difference was also observed in the number of invading cells between miR-193b mimic group (higher) and miR-control group (P<0.05). There were statistical differences in the number of transmembrane cells in the three groups of miR-338-3p cells (P<0.05). The number of transmembrane cells of miR-338-3p mimic and miR-control group was significantly lower than that of miR-338-3p inhibitor group (P<0.05), and the number of transmembrane cells of miR-338-3p mimic group significantly lower than the miR-control group (P<0.05). Conclusion: miR-193b and miR-338-3p was associated with renal clear-cell carcinoma. miR-193b has a function similar to that of a tumor inducer gene, while miR-338-3p functions as a tumor suppressor.
引用
收藏
页码:3467 / 3475
页数:9
相关论文
共 50 条
  • [1] miR-338-3p inhibits the invasion of renal cell carcinoma by downregulation of ALK5
    Zhang, Xiaoqian
    Wang, Chunxia
    Li, Hui
    Niu, Xiaobin
    Liu, Xinwei
    Pei, Dongxu
    Guo, Xiaolan
    Xu, Xiaona
    Li, Yongwei
    ONCOTARGET, 2017, 8 (38) : 64106 - 64113
  • [2] MiR-193b inhibits the growth and metastasis of renal cell carcinoma by targeting IGF1R
    Chen, Jianhui
    Deng, Ting
    Li, Xiaofan
    Cai, Weizhong
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 47 (01) : 2058 - 2064
  • [3] miR-338-3p inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cells
    Chen, Jing-song
    Liang, Li-li
    Xu, Hong-xu
    Chen, Fan
    Shen, Shun-li
    Chen, Wei
    Chen, Lian-Zhou
    Su, Qiao
    Zhang, Long-juan
    Bi, Jiong
    Zeng, Wen-Tao
    Li, Wen
    Ma, Ning
    Huang, Xiao-Hui
    ONCOTARGET, 2017, 8 (42) : 71418 - 71429
  • [4] CircAKT1 acts as a sponge of miR-338-3p to facilitate clear cell renal cell carcinoma progression by up-regulating CAV1
    Zhu, Qingliang
    Zhan, Deming
    Zhu, Peng
    Chong, Yankun
    Yang, Yongguo
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 532 (04) : 584 - 590
  • [5] The Potential of Circulating miR-193b, miR-146b-3p and miR-483-3p as Noninvasive Biomarkers in Cutaneous Melanoma Patients
    Mohammadloo, Atefeh
    Asgari, Yazdan
    Esmaeili-Bandboni, Aghil
    Mazloomi, Mohammad Ali
    Ghasemi, Seyedeh Fatemeh
    Ameri, Sima
    Miri, Seyed Rouhollah
    Hamzelou, Shahin
    Mahmoudi, Hamid Reza
    Veisi-Malekshahi, Ziba
    MOLECULAR BIOTECHNOLOGY, 2024, 66 (10) : 2830 - 2840
  • [6] miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened
    Huang, Xiao-Hui
    Chen, Jing-Song
    Wang, Qian
    Chen, Xi-Lin
    Wen, Li
    Chen, Lian-Zhou
    Bi, Jiong
    Zhang, Long-Juan
    Su, Qiao
    Zeng, Wen-Tao
    JOURNAL OF PATHOLOGY, 2011, 225 (03): : 463 - 472
  • [7] miR-193b/365a cluster controls progression of epidermal squamous cell carcinoma
    Gastaldi, Cecile
    Bertero, Thomas
    Xu, Ning
    Bourget-Ponzio, Isabelle
    Lebrigand, Kevin
    Fourre, Sandra
    Popa, Alexandra
    Cardot-Leccia, Nathalie
    Meneguzzi, Guerrino
    Sonkoly, Eniko
    Pivarcsi, Andor
    Mari, Bernard
    Barbry, Pascal
    Ponzio, Gilles
    Rezzonico, Roger
    CARCINOGENESIS, 2014, 35 (05) : 1110 - 1120
  • [8] Identification of miR-193b Targets in Breast Cancer Cells and Systems Biological Analysis of Their Functional Impact
    Leivonen, Suvi-Katri
    Rokka, Anne
    Ostling, Paivi
    Kohonen, Pekka
    Corthals, Garry L.
    Kallioniemi, Olli
    Perala, Merja
    MOLECULAR & CELLULAR PROTEOMICS, 2011, 10 (07)
  • [9] miR-122 promotes metastasis of clear-cell renal cell carcinoma by downregulating Dicer
    Fan, Yang
    Ma, Xin
    Li, Hongzhao
    Gao, Yu
    Huang, Qingbo
    Zhang, Yu
    Bao, Xu
    Du, Qingshan
    Luo, Guoxiong
    Liu, Kan
    Meng, Qingyu
    Zhao, Chaofei
    Zhang, Xu
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (03) : 547 - 560
  • [10] Mir-338-3p Inhibits Malignant Biological Behaviors of Glioma Cells by Targeting MACC1 Gene
    Shang, Chao
    Hong, Yang
    Guo, Yan
    Xue, Yi-Xue
    MEDICAL SCIENCE MONITOR, 2016, 22